a16z Podcast

Journal Club: Using CRISPR to Prevent Coronavirus and Influenza Infection

Episode Summary

with @vijaypande, @andy23tran, and @lr_bio a16z Journal Club covers a new approach for preventing coronavirus and influenza infection using the genome editing platform CRISPR-Cas.

Episode Notes

In this episode of a16z bio Journal Club, general partner Vijay Pande, bio deal team partner Andy Tran, and bio editor Lauren Richardson discuss a novel CRISPR-Cas-based anti-viral strategy.

The discussion covers the differences between this newly developed prophylactic strategy, traditional vaccines, and anti-viral drugs; how this strategy can be engineered to target a huge range of coronavirus and influenza strains; and the next steps needed to go from paper to practice:

a16z Journal Club (part of the a16z Podcast), curates and covers recent advances from the scientific literature -- what papers we’re reading, and why they matter from our perspective at the intersection of biology & technology (for bio journal club). You can find all these episodes at a16z.com/journalclub.